PVT1 and triple-A syndrome: Furthermore, overexpression of PVT1 in the AngII-induced AAA mouse model led to increased VSMC apoptosis, elevated MMP-2, and MMP-9, reduced TIMP-1, and differentiation into the synthetic SMC phenotype.